STOCKSCREENR

LONA

NASDAQ

LeonaBio, Inc.

$8.57-0.53(-5.82%)Mkt Cap: $33.80M

Key Stats

Market Cap

$33.80M

P/E Ratio

-0.34

EPS

$-25.19

Dividend Yield

0.00%

52-Week Range

$4.25 — $11.91

Volume

30.57K

Avg Volume

0

Beta

2.23

Price Alerts for LONA

Get alerted when LONA hits your target price.

$

Free — enter your email to get started

Valuation

P/E (TTM)

-0.34

Forward P/E

—

PEG Ratio

0.00

P/S (TTM)

0.00

P/B (TTM)

1.53

P/FCF

—

EV/EBITDA

—

EV/Sales

—

Financial Health

ROE (TTM)

-3.41%

ROA (TTM)

-1.15%

ROIC

—

Gross Margin

0.00%

Operating Margin

0.00%

Net Margin

—

Debt/Equity

0.03

Current Ratio

1.88

Growth

EPS Growth (YoY)

—

Revenue Growth (YoY)

—

EPS Growth (3Y)

-0.24%

EPS Growth (5Y)

-1.11%

Sales Growth (3Y)

+0.00%

Sales Growth (5Y)

+0.00%

EPS Est (This Year)

$-4.57

EPS Est (Next Year)

$-2.31

Dividends

Dividend Yield

—

Annual Dividend

—

Payout Ratio

—

Frequency

—

Ex-Dividend Date

—

Cash/Share

$20.66

Analyst Consensus

Ownership

Institutional %

—

Inst. Net Change

—

Insider Net Shares (90d)

—

Outstanding Shares

3.94M

Float

2.68M

Free Float %

68.00%

About

Sector

Healthcare

Industry

Biotechnology

Country

US

Exchange

NASDAQ

IPO Date

2020-09-18

Employees

26

CEO

Mark J. Litton

Index Membership

—

Website

https://leonabio.com

LeonaBio, Inc. (LONA) is a healthcare company in the biotechnology industry listed on the NASDAQ. With a market capitalization of $33.80M, a P/E ratio of -0.34, LONA is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare LONA against other stocks using dozens of fundamental and technical filters.

Similar Stocks

AEON

AEON Biopharma, Inc.

$0.89

-3.58%

$10.53M

NBY

NovaBay Pharmaceuticals, Inc.

$1.88

-3.59%

$50.06M

OSTX

OS Therapies Incorporated

$1.61

-5.29%

$67.68M

AARD

Aardvark Therapeutics, Inc. Common Stock

$5.46

+0.55%

$119.12M

PHIO

Phio Pharmaceuticals Corp.

$1.14

-6.56%

$13.24M

IMUX

Immunic, Inc.

$9.65

+0.31%

$95.23M

Frequently Asked Questions

What is LeonaBio, Inc.'s P/E ratio?

LeonaBio, Inc. (LONA) has a trailing twelve-month (TTM) P/E ratio of -0.34. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.

Does LeonaBio, Inc. pay a dividend?

No, LeonaBio, Inc. (LONA) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.

What is LeonaBio, Inc.'s market cap?

LeonaBio, Inc. (LONA) has a market capitalization of $33.80 million, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.